Biotech stocks Roivant and Pharvaris hit records Tuesday on "blowout" and "bull case" results for lung and swelling disease treatments. The post Why These Two Hot Biotech Stocks Just Surged To Record Highs appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real